CD52 and infection: Importantly, the CD52 gene was knocked out in the CAR T cells to enable the use of ALLO-647, an anti-CD52 monoclonal antibody that depletes host T cells and enhances the persistence of allogeneic CAR T cells but also increases the risk of infections [32].